STOCK TITAN

Pyxis Oncology, Inc. (PYXS) Net Income by Year

PYXS

Pyxis Oncology, Inc. reported a net loss of $79.6M in fiscal year 2025. This represents a decrease of 3.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Pyxis Oncology, Inc. has filed alongside them.

FY2025 annual
Net Income -$79.6M
YoY -3.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PYXS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$79.6M-3.0%-$77.3M-4.8%-$73.8M+38.9%-$120.7M-58.9%-$76.0M-492.3%-$12.8M

PYXS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$25.3M-38.1%-$23.3M-10.0%N/A-$22.0M-3.8%-$18.4M-6.1%-$21.2M-549.8%N/A-$21.2M+8.0%-$17.3M-8.8%-$3.3M+83.1%N/A-$23.0M+16.7%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Pyxis Oncology, Inc. financials

Frequently Asked Questions

What was Pyxis Oncology, Inc.'s net income in fiscal year 2025?

Pyxis Oncology, Inc. reported a net loss of $79.6M in fiscal year 2025.

How fast is Pyxis Oncology, Inc.'s net income growing?

Pyxis Oncology, Inc. (PYXS) net income fell by 3.0% year over year, from -$77.3M to -$79.6M in fiscal year 2025.

How has Pyxis Oncology, Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Pyxis Oncology, Inc. (PYXS) net income went from -$12.8M in fiscal year 2020 to -$79.6M in fiscal year 2025.

Pyxis Oncology, Inc. (PYXS) reported -$25.3M in net income in Q2 2026. This represents a decrease of 38.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Pyxis Oncology, Inc. (PYXS) reported on that line in every period on record.